Maximus Toekomstige groei
Future criteriumcontroles 1/6
De verwachting is dat Maximus de winst en omzet met respectievelijk 8.6% en 3.1% per jaar zal laten groeien, terwijl de winst per aandeel naar verwachting zal groeien met 10.6% per jaar.
Belangrijke informatie
8.6%
Groei van de winst
10.56%
Groei van de winst per aandeel
| Professional Services winstgroei | 15.4% |
| Inkomstengroei | 3.1% |
| Toekomstig rendement op eigen vermogen | n/a |
| Dekking van analisten | Low |
| Laatst bijgewerkt | 11 May 2026 |
Recente toekomstige groei-updates
Analyse-artikel • Aug 10
Earnings Beat: Maximus, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
As you might know, Maximus, Inc. ( NYSE:MMS ) just kicked off its latest third-quarter results with some very strong...Analyse-artikel • May 11
Maximus, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Maximus, Inc. ( NYSE:MMS ) just released its latest quarterly results and things are looking bullish. It was overall a...Recent updates
Analyse-update • May 04
MMS: Share Buybacks And Stable Outlook Will Support Future Returns
Analysts have modestly lifted their price target on Maximus, with the updated valuation framework reflecting a steady $110 fair value, supported by slightly higher assumed discount rates and a marginally richer future P/E multiple. What's in the News Maximus narrowed its revenue guidance for fiscal 2026, with expected revenue now in a range of US$5.2b to US$5.35b.
Analyse-update • Apr 19
MMS: Share Repurchases And AI Accuracy Solutions Will Support Future Upside
Analysts have slightly refined their view on Maximus, keeping the fair value estimate steady at $95 while modestly adjusting underlying assumptions for discount rate, revenue growth, profit margin, and future P/E. Together, these updates support the unchanged price target.Analyse-update • Apr 05
MMS: Buybacks And Higher Dividend Will Support Future Upside Potential
Analysts have modestly adjusted their price target on Maximus to $95 to reflect updated assumptions around the discount rate, revenue growth, profit margins, and future P/E multiples, while keeping the overall fair value estimate steady. What's in the News From October 1, 2025 to December 31, 2025, Maximus repurchased 40,000 shares, representing 0.07%, for US$31.1 million, completing a total buyback of 9,007,470 shares, or 15.08%, for US$709.68 million under the program announced on May 7, 2020 (Key Developments).Analyse-update • Mar 22
MMS: Share Repurchases And Higher Dividend Will Support Future Upside
Analysts have reiterated a $95.00 price target for Maximus, citing updated assumptions for discount rate, revenue growth, profit margin, and future P/E that remain broadly consistent with prior views. What's in the News Maximus narrowed revenue guidance for fiscal 2026 to a range of US$5.2b to US$5.35b, with US$25 million of the change from prior guidance linked to the divested U.S. Services Segment business (Corporate guidance).Analyse-update • Mar 07
MMS: Dividend Hike And Buybacks Will Support Future Share Returns
Analysts have maintained their $110 price target for Maximus, citing slightly revised assumptions for the discount rate, profit margin, and future P/E as the main factors supporting this reaffirmed view. What's in the News Management narrowed fiscal 2026 revenue guidance to a range of US$5.2b to US$5.35b, with US$25 million of the change tied to the divested U.S. Services Segment business (Corporate Guidance).Analyse-update • Feb 21
MMS: Share Repurchases And Higher Dividend Will Support Future Upside
Analysts have raised their price target on Maximus to $95, reflecting updated assumptions for discount rate, revenue growth, profit margin, and future P/E. Together, these revisions suggest a slightly refined view of the company’s valuation profile.Analyse-update • Feb 07
MMS: Higher Margin Outlook And Dividend Increase Will Support Upside
Analysts have lifted their price target on Maximus from US$90 to US$95, pointing to updated assumptions around higher revenue growth, a stronger profit margin profile, and a lower future P/E multiple as key drivers of the change. What's in the News Maximus narrowed its fiscal 2026 revenue guidance to a range of US$5.2b to US$5.35b, with US$25 million of the change tied to the divestiture of its U.S. Services Segment business (Corporate guidance).Analyse-artikel • Jan 24
Maximus (NYSE:MMS) Is Increasing Its Dividend To $0.33
Maximus, Inc. ( NYSE:MMS ) will increase its dividend from last year's comparable payment on the 2nd of March to $0.33...Analyse-update • Jan 23
MMS: Buybacks Dividend Hike And New Contract Will Support Future Earnings
Analysts have kept their fair value estimate for Maximus steady at $110, with only slight technical adjustments to inputs such as the discount rate and future P/E. They view these as refinements rather than a shift in their overall outlook.Analyse-artikel • Jan 10
Maximus (NYSE:MMS) Is Increasing Its Dividend To $0.33
Maximus, Inc. ( NYSE:MMS ) has announced that it will be increasing its dividend from last year's comparable payment on...
Analyse-update • Jan 09
MMS: Future Defense And Health Contracts Will Support A Higher Earnings Multiple
Analysts have nudged their price target on Maximus to US$125, reflecting refined assumptions that include slightly higher projected revenue growth, modestly better profit margins and a marginally lower future P/E multiple. What's in the News The Board approved a quarterly cash dividend of US$0.33 per share, a 10% increase from the prior US$0.30 dividend.Analyse-update • Dec 22
MMS: Future Defense And Health Contracts Will Drive Stronger Earnings Multiple
Analysts have raised their price target on Maximus by 5 dollars to approximately 125 dollars per share, which reflects slightly stronger confidence in the company’s long term earnings multiple despite modestly softer expectations for revenue growth and profit margins. What's in the News Issued fiscal 2026 earnings guidance, projecting revenue between 5.225 billion and 5.425 billion dollars, signaling confidence in multi year growth visibility (company guidance) Completed a major share repurchase tranche, buying back 1,721,139 shares in the latest quarter and 8,967,470 shares in total, or about 15 percent of shares outstanding, for 678.58 million dollars (buyback update) Won a new Joint Cyber Command and Control Readiness contract with the U.S. Air Force, with a potential value of 86 million dollars over a base year plus up to four option years and an extension, expanding cyber and defense work (client announcement) Secured a 31 million dollar four year contract with the Massachusetts Health Connector to provide enrollment, premium billing, and a redesigned digital member portal serving more than 370,000 marketplace members (client announcement) Awarded a five year 62 million dollar contract to continue and expand the Pennsylvania Enrollment Assistance Program, including support for Children's Health Insurance Program recipients and new AI enabled digital tools (client announcement) Valuation Changes Fair Value: increased modestly from 120 dollars to 125 dollars per share, reflecting a slightly higher intrinsic valuation.Analyse-update • Dec 08
MMS: Share Repurchases Will Support Stronger Future Earnings Power
Analysts have modestly raised their price target on Maximus to approximately $110.00 per share from about $110.00, citing slightly lower perceived risk, stable long term growth expectations, and a sustained margin outlook that supports a steady valuation multiple. What's in the News Completed repurchase of 8,967,470 shares, about 15.01% of shares outstanding, for $678.58 million under the buyback program announced in 2020, including 1,721,139 shares bought in the latest tranche for $150.84 million (company filing) Issued fiscal 2026 earnings guidance and projected revenue between $5.225 billion and $5.425 billion (company guidance) Awarded a new Joint Cyber Command and Control Readiness contract by the U.S. Air Force, with a potential value of $86 million to support engineering, software, and architecture enhancements over a multiyear term (company announcement) Secured a $31 million, four year contract with the Massachusetts Health Connector to provide enrollment and premium billing services and to launch a redesigned digital member portal for more than 370,000 marketplace members (company announcement) Won a five year, $62 million renewal from Pennsylvania's Department of Human Services to continue and expand the Enrollment Assistance Program, including new support for CHIP recipients and deployment of AI based training tools for contact center staff (company announcement) Valuation Changes Fair Value: unchanged at approximately $110.00 per share, indicating no material shift in the intrinsic value estimate.Analyse-update • Nov 24
MMS: Share Repurchase and New Contracts Will Drive Stronger Profit Margins
Analysts have raised their price target for Maximus from $105 to $110, citing a slight improvement in projected profit margins. This comes despite moderating revenue growth expectations and updated financial modeling.Analyse-artikel • Oct 09
Maximus (NYSE:MMS) Is Due To Pay A Dividend Of $0.30
The board of Maximus, Inc. ( NYSE:MMS ) has announced that it will pay a dividend on the 1st of December, with...Seeking Alpha • Sep 23
Maximus: A Stable Compounder Trading At Just 12x Earnings
Summary Maximus has proven its business model resilient, with stable top- and bottom-line growth, margin expansion above historical averages, and strong EPS momentum supported by share buybacks. Federal Services is the growth engine, now 57% of revenue, where higher clinical volumes, scalability, and automation are driving margins above 18%, well ahead of other segments. U.S. Services faces YoY declines after pandemic unwinding, but longer-term growth opportunities remain through OBBBA-driven Medicaid checks, SNAP accuracy programs, and potential UI outsourcing. Demographic tailwinds are significant, with nearly 9 million more Americans aged 65+ by 2030, supporting demand for Medicaid, disability, and federal health assessments over the long run. Trading at only 12x forward earnings and raising FY25 EPS guidance Maximus offers strong upside in my valuation scenarios, with risks mainly from budget pressure and possible slower growth. Read the full article on Seeking AlphaAnalyse-update • Sep 05
Federal Legislation And Digital Transformation Will Expand Compliance Demand
With no change in either the discount rate or future P/E, Maximus’s consensus analyst price target remained stable at $105.00. What's in the News Maximus completed its $527.74 million share buyback program, repurchasing 11.95% of shares, but made no additional repurchases between April and June 2025.Analyse-artikel • Sep 01
Maximus (NYSE:MMS) Ticks All The Boxes When It Comes To Earnings Growth
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...Analyse-artikel • Aug 10
Earnings Beat: Maximus, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
As you might know, Maximus, Inc. ( NYSE:MMS ) just kicked off its latest third-quarter results with some very strong...Analyse-artikel • Jul 24
Estimating The Intrinsic Value Of Maximus, Inc. (NYSE:MMS)
Key Insights Maximus' estimated fair value is US$73.82 based on 2 Stage Free Cash Flow to Equity Current share price of...Analyse-artikel • Jul 10
Maximus (NYSE:MMS) Is Paying Out A Dividend Of $0.30
Maximus, Inc.'s ( NYSE:MMS ) investors are due to receive a payment of $0.30 per share on 31st of August. This means...Analyse-artikel • Jul 02
Improved Earnings Required Before Maximus, Inc. (NYSE:MMS) Shares Find Their Feet
Maximus, Inc.'s ( NYSE:MMS ) price-to-earnings (or "P/E") ratio of 13.5x might make it look like a buy right now...Analyse-artikel • May 26
Maximus (NYSE:MMS) Has A Pretty Healthy Balance Sheet
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Analyse-artikel • May 11
Maximus, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Maximus, Inc. ( NYSE:MMS ) just released its latest quarterly results and things are looking bullish. It was overall a...Analyse-artikel • May 08
Maximus (NYSE:MMS) Has Announced A Dividend Of $0.30
Maximus, Inc. ( NYSE:MMS ) has announced that it will pay a dividend of $0.30 per share on the 31st of May. This...Analyse-artikel • May 01
Maximus' (NYSE:MMS) Returns On Capital Not Reflecting Well On The Business
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Analyse-artikel • Apr 11
Maximus (NYSE:MMS) Has Affirmed Its Dividend Of $0.30
Maximus, Inc. ( NYSE:MMS ) will pay a dividend of $0.30 on the 31st of May. This means that the annual payment will be...Analyse-artikel • Apr 01
Maximus, Inc. (NYSE:MMS) Looks Inexpensive But Perhaps Not Attractive Enough
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 18x, you may...Analyse-artikel • Feb 24
Calculating The Intrinsic Value Of Maximus, Inc. (NYSE:MMS)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Maximus fair value estimate is US$79.27 With US$66.00 share...Analyse-artikel • Feb 06
Maximus (NYSE:MMS) Has Affirmed Its Dividend Of $0.30
The board of Maximus, Inc. ( NYSE:MMS ) has announced that it will pay a dividend of $0.30 per share on the 28th of...Analyse-artikel • Jan 23
Maximus (NYSE:MMS) Will Pay A Dividend Of $0.30
The board of Maximus, Inc. ( NYSE:MMS ) has announced that it will pay a dividend on the 28th of February, with...Seeking Alpha • Jan 13
Maximus: Navigating Through Some Uncertainty
Summary Maximus, Inc. delivered a strong FY2024, but shares dropped due to a lackluster FY2025 outlook and uncertainty over the incoming Trump administration. The company operates in three segments and has a 90% rebid win rate and secure programs. The stock has seen some recent insider buying, a new analyst firm upgrade, and the company has an improving balance sheet. An analysis around Maximus follows in the paragraphs below. Read the full article on Seeking AlphaAnalyse-artikel • Jan 09
Maximus (NYSE:MMS) Has Announced A Dividend Of $0.30
Maximus, Inc.'s ( NYSE:MMS ) investors are due to receive a payment of $0.30 per share on 28th of February. Based on...Analyse-artikel • Dec 10
Maximus, Inc.'s (NYSE:MMS) Business And Shares Still Trailing The Market
With a price-to-earnings (or "P/E") ratio of 14x Maximus, Inc. ( NYSE:MMS ) may be sending bullish signals at the...Analyse-artikel • Nov 11
Maximus (NYSE:MMS) Will Want To Turn Around Its Return Trends
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...Analyse-artikel • Oct 24
Maximus (NYSE:MMS) Is Paying Out A Dividend Of $0.30
The board of Maximus, Inc. ( NYSE:MMS ) has announced that it will pay a dividend on the 30th of November, with...Analyse-artikel • Oct 10
Maximus (NYSE:MMS) Has Affirmed Its Dividend Of $0.30
Maximus, Inc.'s ( NYSE:MMS ) investors are due to receive a payment of $0.30 per share on 30th of November. This means...Analyse-artikel • Oct 01
We Think Maximus (NYSE:MMS) Can Stay On Top Of Its Debt
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 9/30/2027 | 5,551 | 428 | 484 | 524 | 2 |
| 9/30/2026 | 5,296 | 404 | 491 | 531 | 2 |
| 3/31/2026 | 5,318 | 373 | 372 | 412 | N/A |
| 12/31/2025 | 5,374 | 372 | 218 | 265 | N/A |
| 9/30/2025 | 5,431 | 319 | 366 | 429 | N/A |
| 6/30/2025 | 5,429 | 316 | -126 | -56 | N/A |
| 3/31/2025 | 5,395 | 300 | 219 | 326 | N/A |
| 12/31/2024 | 5,382 | 284 | 281 | 414 | N/A |
| 9/30/2024 | 5,306 | 307 | 383 | 515 | N/A |
| 6/30/2024 | 5,250 | 294 | 364 | 496 | N/A |
| 3/31/2024 | 5,124 | 235 | 169 | 291 | N/A |
| 12/31/2023 | 4,983 | 186 | 373 | 471 | N/A |
| 9/30/2023 | 4,905 | 162 | 224 | 314 | N/A |
| 6/30/2023 | 4,822 | 172 | 211 | 290 | N/A |
| 3/31/2023 | 4,759 | 172 | 286 | 353 | N/A |
| 12/31/2022 | 4,729 | 190 | 93 | 158 | N/A |
| 9/30/2022 | 4,631 | 204 | 234 | 290 | N/A |
| 6/30/2022 | 4,560 | 187 | 400 | 440 | N/A |
| 3/31/2022 | 4,678 | 250 | 314 | 349 | N/A |
| 12/31/2021 | 4,460 | 280 | 382 | 416 | N/A |
| 9/30/2021 | 4,254 | 291 | 481 | 517 | N/A |
| 6/30/2021 | 4,072 | 303 | 351 | 395 | N/A |
| 3/31/2021 | 3,730 | 273 | 370 | 415 | N/A |
| 12/31/2020 | 3,589 | 220 | 216 | 255 | N/A |
| 9/30/2020 | 3,462 | 215 | 204 | 245 | N/A |
| 6/30/2020 | 3,293 | 211 | 133 | 189 | N/A |
| 3/31/2020 | 3,122 | 209 | 271 | 339 | N/A |
| 12/31/2019 | 3,040 | 244 | N/A | 385 | N/A |
| 9/30/2019 | 2,887 | 241 | N/A | 357 | N/A |
| 6/30/2019 | 2,690 | 227 | N/A | 392 | N/A |
| 3/31/2019 | 2,557 | 224 | N/A | 327 | N/A |
| 12/31/2018 | 2,434 | 218 | N/A | 338 | N/A |
| 9/30/2018 | 2,392 | 221 | N/A | 317 | N/A |
| 6/30/2018 | 2,455 | 228 | N/A | 273 | N/A |
| 3/31/2018 | 2,457 | 225 | N/A | 317 | N/A |
| 12/31/2017 | 2,467 | 222 | N/A | 304 | N/A |
| 9/30/2017 | 2,451 | 209 | N/A | 336 | N/A |
| 6/30/2017 | 2,453 | 207 | N/A | 324 | N/A |
| 3/31/2017 | 2,470 | 202 | N/A | 295 | N/A |
| 12/31/2016 | 2,454 | 198 | N/A | 250 | N/A |
| 9/30/2016 | 2,403 | 178 | N/A | 180 | N/A |
| 6/30/2016 | 2,359 | 163 | N/A | 133 | N/A |
| 3/31/2016 | 2,314 | 152 | N/A | 166 | N/A |
| 12/31/2015 | 2,190 | 143 | N/A | 151 | N/A |
| 9/30/2015 | 2,100 | 158 | N/A | 206 | N/A |
| 6/30/2015 | 1,957 | 159 | N/A | 229 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei MMS ( 8.6% per jaar) ligt boven de spaarquote ( 3.5% ).
Winst versus markt: De winst van MMS ( 8.6% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 16.7% per jaar).
Hoge groeiwinsten: De winst van MMS zal naar verwachting groeien, maar niet aanzienlijk.
Omzet versus markt: De omzet van MMS ( 3.1% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 11.6% per jaar).
Hoge groei-inkomsten: De omzet van MMS ( 3.1% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van MMS naar verwachting over 3 jaar hoog zal zijn
Ontdek groeibedrijven
Bedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/05/11 08:43 |
| Aandelenkoers aan het einde van de dag | 2026/05/11 00:00 |
| Inkomsten | 2026/03/31 |
| Jaarlijkse inkomsten | 2025/09/30 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen over hoe je onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
Maximus, Inc. wordt gevolgd door 12 analisten. 2 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Matthew Gillmor | Baird |
| Richard Close | Canaccord Genuity |
| Constantine Davides | Citizens JMP Securities, LLC |